{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:27:06Z","timestamp":1763036826981},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,3,23]],"date-time":"2014-03-23T00:00:00Z","timestamp":1395532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00280-014-2448-2","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T15:50:20Z","timestamp":1395503420000},"page":"1147-1154","source":"Crossref","is-referenced-by-count":14,"title":["Treatment results and prognostic factors for advanced squamous cell carcinoma of the hypopharynx treated with concurrent chemoradiotherapy"],"prefix":"10.1007","volume":"73","author":[{"given":"Takahide","family":"Taguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goshi","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichiro","family":"Yabuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Oridate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,23]]},"reference":[{"key":"2448_CR1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/00016480902914080","volume":"130","author":"JM Prades","year":"2010","unstructured":"Prades JM, Lallemant B, Garrel R, Reyt E, Righini C, Schmitt T, Remini N, Saban-Roche L, Timoshenko AP, Trombert B, Guerrier B (2010) Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma. Acta Otolaryngol 130:150\u2013155","journal-title":"Acta Otolaryngol"},{"key":"2448_CR2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/00034894911000S401","volume":"152","author":"DH Hussey","year":"1991","unstructured":"Hussey DH, Latourette HB, Panje WR (1991) Head and neck cancer: an analysis of the incidence, patterns of treatment, and survival at the University of Iowa. Ann Otol Rhinol Laryngol Suppl 152:2\u201316","journal-title":"Ann Otol Rhinol Laryngol Suppl"},{"key":"2448_CR3","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/88.13.890","volume":"88","author":"JL Lefebvre","year":"1996","unstructured":"Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890\u2013899","journal-title":"J Natl Cancer Inst"},{"key":"2448_CR4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jnci\/djp007","volume":"101","author":"Y Pointreau","year":"2009","unstructured":"Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J, Faivre S, Guerrif S, Alfonsi M, Calais G (2009) Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101:498\u2013506","journal-title":"J Natl Cancer Inst"},{"key":"2448_CR5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/annonc\/mdn752","volume":"20","author":"MR Posner","year":"2009","unstructured":"Posner MR, Norris CM, Wirth LJ, Shin DM, Cullen KJ, Winquist EW, Blajman CR, Mickiewicz EA, Frenette GP, Plinar LF, Cohen RB, Steinbrenner LM, Freue JM, Gorbunova VA, Tjulandin SA, Raez LE, Adkins DR, Tishler RB, Roessner MR, Haddad RI (2009) Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol 20:921\u2013927","journal-title":"Ann Oncol"},{"key":"2448_CR6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00280-009-1217-0","volume":"66","author":"M Tsukuda","year":"2010","unstructured":"Tsukuda M, Ishitoya J, Matsuda H, Horiuchi C, Taguchi T, Takahashi M, Nishimura G, Kawakami M, Watanabe M, Niho T, Kawano T, Ikeda Y, Sakuma Y, Shiono O, Komatsu M (2010) Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol 66:729\u2013736","journal-title":"Cancer Chemother Pharmacol"},{"key":"2448_CR7","first-page":"713","volume":"23","author":"T Taguchi","year":"2003","unstructured":"Taguchi T, Ikeda Y, Mikami Y, Kawai S, Arai Y, Mochimatsu I, Tsukuda M (2003) Combined radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinoma. Anticancer Res 23:713\u2013717","journal-title":"Anticancer Res"},{"key":"2448_CR8","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00280-009-0946-4","volume":"64","author":"M Tsukuda","year":"2009","unstructured":"Tsukuda M, Ishitoya J, Mikami Y, Matsuda H, Horiuchi C, Taguchi T, Satake K, Kawano T, Takahashi M, Nishimura G, Kawakami M, Sakuma Y, Watanabe M, Shiono O, Komatsu M, Yamashita Y (2009) Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and\/or cases with comorbidity. Cancer Chemother Pharmacol 64:945\u2013952","journal-title":"Cancer Chemother Pharmacol"},{"key":"2448_CR9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/jjco\/hyi058","volume":"35","author":"T Kodaira","year":"2005","unstructured":"Kodaira T, Fuwa N, Furutani K, Tachibana H, Yamazaki T (2005) Phase I trial of weekly docetaxel and concurrent radiotherapy for head and neck cancer in elderly patients or patients with complications. Jpn J Clin Oncol 35:173\u2013176","journal-title":"Jpn J Clin Oncol"},{"key":"2448_CR10","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341\u20131346","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2448_CR11","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1200\/JCO.2007.14.8841","volume":"26","author":"M Machtay","year":"2008","unstructured":"Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, Forastiere A, Ang KK (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26:3582\u20133589","journal-title":"J Clin Oncol"},{"key":"2448_CR12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/1097-0142(20010201)91:3<548::AID-CNCR1033>3.0.CO;2-A","volume":"91","author":"M Suntharalingam","year":"2001","unstructured":"Suntharalingam M, Haas ML, Van Echo DA, Haddad R, Jacobs MC, Levy S, Gray WC, Ord RA, Conley BA (2001) Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck. Cancer 91:548\u2013554","journal-title":"Cancer"},{"issue":"Suppl A","key":"2448_CR13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0305-7372(85)90026-X","volume":"12","author":"EB Douple","year":"1985","unstructured":"Douple EB, Richmond RC, O\u2019Hara JA, Coughlin CT (1985) Carboplatin as a potentiator of radiation therapy. Cancer Treat Rev 12(Suppl A):111\u2013124","journal-title":"Cancer Treat Rev"},{"key":"2448_CR14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00000421-199810000-00013","volume":"21","author":"AD Colevas","year":"1998","unstructured":"Colevas AD, Posner MR (1998) Docetaxel in head and neck cancer: a review. Am J Clin Oncol 21:482\u2013486","journal-title":"Am J Clin Oncol"},{"key":"2448_CR15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0889-8588(18)30413-1","volume":"5","author":"KK Fu","year":"1991","unstructured":"Fu KK, Phillips TL (1991) Biologic rationale of combined radiotherapy and chemotherapy. Hematol Oncol Clin North Am 5:737\u2013751","journal-title":"Hematol Oncol Clin North Am"},{"key":"2448_CR16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0360-3016(91)90091-H","volume":"20","author":"SR Smalley","year":"1991","unstructured":"Smalley SR, Kimler BF, Evans RG (1991) 5-Fluorouracil modulation of radiosensitivity in cultured human carcinoma cells. Int J Radiat Oncol Biol Phys 20:207\u2013211","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2448_CR17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/00016480701200251","volume":"127","author":"H Katori","year":"2007","unstructured":"Katori H, Tsukuda M, Taguchi T (2007) Concurrent chemoradiotherapy with carboplatin and uracil-f tegafur (UFT) for patients with poor performance status with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Acta Otolaryngol 127:1099\u20131104","journal-title":"Acta Otolaryngol"},{"key":"2448_CR18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10147-003-0375-z","volume":"9","author":"M Fujii","year":"2004","unstructured":"Fujii M, Tsukuda M, Satake B, Kubota A, Kida A, Kohno N, Okami K, Inuyama Y (2004) Phase I\/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck. Int J Clin Oncol 9:107\u2013112","journal-title":"Int J Clin Oncol"},{"key":"2448_CR19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.oraloncology.2011.11.001","volume":"48","author":"WL Lodder","year":"2012","unstructured":"Lodder WL, Pameijer FA, Rasch CR, van den Brekel MW, Balm AJ (2012) Prognostic significance of radiologically determined neck node volume in head and neck cancer: a systematic review. Oral Oncol 48:298\u2013302","journal-title":"Oral Oncol"},{"key":"2448_CR20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000091803","volume":"68","author":"YA Tsou","year":"2006","unstructured":"Tsou YA, Hua JH, Lin MH, Tsai MH (2006) Analysis of prognostic factors of chemoradiation therapy for advanced hypopharyngeal cancer\u2014does tumor volume correlate with central necrosis and tumor pathology? ORL J Otorhinolaryngol Relat Spec 68:206\u2013212","journal-title":"ORL J Otorhinolaryngol Relat Spec"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2448-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-014-2448-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2448-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T20:30:48Z","timestamp":1565296248000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-014-2448-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,23]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["2448"],"URL":"https:\/\/doi.org\/10.1007\/s00280-014-2448-2","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,23]]}}}